Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas

Raghav Vij, Carina Danchik, Conor Crawford, Quigly Dragotakes, Arturo Casadevall
J. Andrew Alspaugh, Editor
Raghav Vij
aDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raghav Vij
Carina Danchik
aDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carina Danchik
Conor Crawford
aDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
bCentre for Synthesis and Chemical Biology, University College Dublin, Belfield, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Conor Crawford
Quigly Dragotakes
aDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Quigly Dragotakes
Arturo Casadevall
aDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arturo Casadevall
J. Andrew Alspaugh
Duke University Medical Center
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00310-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Cryptococcus neoformans and Cryptococcus gattii are pathogenic fungi that cause significant morbidity and mortality. Cell surface hydrophobicity (CSH) is a biophysical parameter that influences the adhesion of fungal cells or spores to biotic and abiotic surfaces. C. neoformans is encased by polysaccharide capsule that is highly hydrophilic and is a critical determinant of virulence. In this study, we report large differences in the CSH of some C. neoformans and C. gattii strains. The capsular polysaccharides of C. neoformans strains differ in repeating motifs and therefore vary in the number of hydroxyl groups, which, along with higher-order structure of the capsule, may contribute to the variation in hydrophobicity that we observed. We found that cell wall composition, in the context of chitin-chitosan content, does not influence CSH. For C. neoformans, CSH correlated with phagocytosis by natural soil predator Acanthamoeba castellanii. Furthermore, capsular binding of the protective antibody (18B7), but not the nonprotective antibody (13F1), altered the CSH of C. neoformans strains. Variability in CSH could be an important characteristic in comparing the biological properties of cryptococcal strains.

IMPORTANCE The interaction of a microbial cell with its environment is influenced by the biophysical properties of a cell. The affinity of the cell surface for water, defined by the cell surface hydrophobicity (CSH), is a biophysical parameter that varies among different strains of Cryptococcus neoformans. The CSH influences the phagocytosis of the yeast by its natural predator in the soil, the amoeba. Studying variation in biophysical properties like CSH gives us insight into the dynamic host-predator interaction and host-pathogen interaction in a damage-response framework.

INTRODUCTION

The encapsulated Basidiomycetes that comprise the Cryptococcus species complex include several pathogenic species including Cryptococcus neoformans and Cryptococcus gattii. Cryptococcus spp. have a worldwide geographic distribution and are unusual among fungal pathogens in that they have polysaccharide capsules that are essential for mammalian virulence.

Human infection usually begins in the lung. Infectious propagules of C. neoformans, in the form of spore or yeast, may be inhaled to cause a pulmonary infection that is usually cleared in immunocompetent hosts or becomes latent. Conditions that impair immunity, such as HIV infection, are associated with disseminated disease, which usually manifests clinically as a meningoencephalitis. Recent evidence suggests that the nature of the infectious propagule has a significant effect on the outcome of the infection, as spores from C. neoformans cause significantly higher fungal burden in the brain of a murine model than small encapsulated yeast (1).

C. neoformans has been isolated from avian guano, soil, or arboreal sources. C. gattii has been isolated from trees, soil, freshwater, and seawater. There are three serotypes of C. neoformans, now referred to as Cryptococcus neoformans var. neoformans (serotype D), Cryptococcus neoformans var. grubii (serotype A), and hybrid (serotype AD). Phylogenetic evidence suggests that they may be classified as separate species, C. neoformans, Cryptococcus deneoformans, and hybrid, respectively (2). Interestingly, C. neoformans var. grubii has been isolated from 63% of clinical samples collected worldwide, followed by C. neoformans hybrid (6%) and C. neoformans var. neoformans (5%) (3, 4). The genomic diversity in the cryptococcal species complex may contribute to differences in the biophysical properties of cell surfaces within the Cryptococcus species complex.

C. neoformans and C. gattii cells are surrounded by a polysaccharide capsule that can dramatically vary in size during infection (5) and helps the pathogen evade the mammalian immune system. Highly branched polysaccharides (6) radiate outward from the cell wall, to form a dense matrix whose porosity increases with the distance from the cell wall, with reducing ends localized at the cell wall (7, 8). The capsule is primarily composed of glucuronoxylomannan (GXM; 98%), along with minor components glucuronoxylomannogalactan (GXMGal) and mannoproteins. GXM contains a core repeating structure of a α-(1→3)-mannose triad, with a β-(1→2) glucuronic acid branch on every third mannose (9). The capsules of different serotypes of C. neoformans and C. gattii have distinguishable polysaccharide motifs characterized by a varied degree of β-(1→2) or β-(1→4) xylose substitutions, and 6-O-acetyl substitutions along the mannan backbone (10). Polysaccharides are highly enriched in hydroxyl groups and form an extensive network of intramolecular and intermolecular hydrogen bonds, which includes bonding with water molecules. Therefore, polysaccharides are intrinsically hydrophilic molecules, which could provide an explanation for approximately 95% of the capsule’s weight (11). Structure-function relationships in glycans are poorly understood, but branching and substitution of polysaccharides likely affect the intra- and intermolecular hydrogen bonds, and therefore the rigidity of the polymer, thereby affecting the polysaccharide’s ability to form hydrogen bonds with water, which would result in variation of the conformation and hydrophobicity (12–15).

Factors that affect the biophysical parameters of the microbial surface of the Cryptococcus species complex have been previously described. For instance, melanization, capsule induction, and binding of capsular antibody alter the cell surface charge, which also varies by strain (16). Chronological aging of the yeast and antibody binding alter the elasticity of the polysaccharide capsule that surrounds the C. neoformans cell (17, 18).

Cell surface hydrophobicity (CSH) is a property of a microbial surface that reflects the affinity of components of the microbe’s cell surface for water and is calculated by estimating the affinity of cell surfaces for hydrophobic substances like hydrophobic columns, solvents, or polystyrene beads (Fig. 1). The biological role of CSH has been studied in bacteria such as Staphylococcus aureus and some fungi and has been succinctly reviewed (19). Previous studies of Candida albicans have established the importance of CSH for the interaction of the pathogen with the host tissue (20). Furthermore, strain-specific variation in CSH of clinical isolates and variation between species of Candida species complex have been reported (21).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Methods for estimation of C. neoformans CSH. (A) CSH estimated by MATH assay that quantifies the interaction of C. neoformans cells in a suspension with the hydrocarbon solvent n-hexadecane. CSH% was calculated as the percent change in OD of a C. neoformans cell suspension after vortexing the mixture of cells with n-hexadecane. (B) In addition, we estimated CSH by visualizing the interaction between C. neoformans cells and hydrophobic beads (0.8 μm) in a hemocytometer and counting cells that had >3 beads/100 cells to calculate CSH%. Image created with BioRender.

The biophysical properties of the infectious propagule of C. neoformans in the form of yeast or spore influence the interaction of the yeast with its environment and inside the host during infection. For example, during infection, C. neoformans interacts with lung epithelial cells and macrophages and can pass through the blood-brain barrier. In the environment, Cryptococcus species complex is believed to interact with amoebas (22) and nematodes (23). Furthermore, hydrophobicity may influence the phagocytosis of microbial cells or particles by amoebas (24).

In this study, we report variation in CSH of C. neoformans and C. gattii strains using two independent methods. Further, we observed that CSH correlated positively with phagocytosis by Acanthamoeba castellanii. Additionally, the higher-order structure of the capsule is affected by the different capsular polysaccharide motifs that vary between serotypes of C. neoformans and C. gattii, which may influence the CSH. We also found that binding of protective but not nonprotective antibodies altered the hydrophobicity of C. neoformans grown in capsule induction medium.

RESULTS

Cryptococcal species manifest significant differences in CSH.Measuring CSH by the MATH (microbial adhesion to hydrocarbons) and hydrophobic microsphere techniques (Fig. 1) revealed considerable variability among cells of C. neoformans and C. gattii strains cultured in Sabouraud dextrose broth (Fig. 2). By MATH assay, we found that serotype D strains B3501 and JEC21 were significantly more hydrophobic than the reference strain H99 (Fig. 2A). By the hydrophobic microsphere assay, we found that all strains of serotype D for which CSH was estimated, including B3501, ATCC 24067, and JEC21, were significantly more hydrophobic than the reference strain H99 (Fig. 2B). However, there was considerable strain-to-strain variation, and no pattern emerged regarding differences between serotypes or species, except for the notable finding that the most strains manifesting highest CSH were C. neoformans serotype D.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

CSH of C. neoformans differs by strain. Graphical representation of CSH of C. neoformans and C. gattii strains. (A) Graphical representation of CSH estimated by MATH assay. (B) Graphical representation of CSH estimated by hydrophobic microsphere assay (left). Experiments have been performed 2 to 6 times independently, as indicated by individual data points. Circles indicate data points of CSH of an encapsulated strain of C. neoformans and C. gattii. Error bars represent the standard deviation of the mean. (C) Representative image of a mixture of hydrophobic beads with C. neoformans strain H99 (top) and relatively hydrophobic C. neoformans strain B3501 (bottom) used for the assay. Hydrophobic beads (small spheres, approximately 0.8 μm in diameter) adhere to the cell surface due to the high hydrophobicity of the B3501 cell, covering it almost completely. The hydrophobic beads are all but absent from the surface of H99 cells. Ordinary one-way analysis of variance was used to compare the CSH of C. neoformans strain H99 with the CSH of C. neoformans and C. gattii strains. The following symbols were used to annotate the statistical significance of the results: ***, P ≤ 0.001; ****, P ≤ 0.0001.

Capsule composition may influence the CSH.The capsule that surrounds the C. neoformans cell is thought to be highly hydrophilic and is primarily composed of water (11). Hence, we sought to ascertain its contribution to CSH in C. neoformans strain H99 (serotype A) by comparing encapsulated H99 and the nonencapsulated cap59 strain. To our surprise, we observed no major difference in CSH between H99 and cap59 cells grown in Sabouraud dextrose broth, by the MATH assay (Fig. 3A). However, when grown in capsule-inducing minimum medium (25), the nonencapsulated strain bound more hydrophobic beads than the encapsulated strains (Fig. 3B). Next, we compared the CSH of C. neoformans strain B3501 (serotype D) to the acapsular cap67 mutant, on the B3501 background (26, 27). We observed a significant decrease in the CSH by MATH assay (Fig. 3A).

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Capsular motifs, and not the cell wall composition, may contribute to the variation in hydrophobicity of C. neoformans. (A) Comparison of the CSH of C. neoformans H99 grown in Sabouraud broth with those of C. neoformans H99 grown in MM and acapsular cap59 strain and comparison of the CSH of strain B3501 with that of acapsular cap67 strain. One-way analysis of variance and t test were used, respectively, to compare the means. Data have been compiled from separate experiments to draw comparisons and study the influence of presence or induction of capsule on the CSH of C. neoformans. Each data point represents a biological replicate, and the error bar represents the SD of the mean. (B) CSH% measured by a hydrophobic bead assay of C. neoformans strain H99 and acapsular strain cap59 grown in capsule induction medium. The experiment was performed in two independent replicates, as represented by data points about the median. (C) Lipophilicity, log P, of dominant carbohydrate motifs in the carbohydrate was predicted by an equation proposed by Mannhold et al. (28). M4 was found to be the most hydrophobic motif and M1 the least. The number of hydroxyl groups on each polysaccharide motif was calculated (below). Glycan notification followed the Symbol Nomenclature for Glycans (SNFG) (71). (D) No significant differences were found when the CSH% of C. neoformans strain K99 was compared to those of chitin deacetylase 1 mutant (cda1Δ) and chitin deacetylase triple-knockout mutant (cda123Δ) strains as measured by hydrophobic microsphere assay. The following symbols were used to annotate the statistical significance of the results: *, P ≤ 0.05.

Different strains and serotypes of C. neoformans and C. gattii have different dominant carbohydrate motifs in their capsule (10) that may influence the experimentally observed variation in CSH. To test this hypothesis, we used in silico method described by Mannhold et al. (28), to calculate and compare the lipophilicity (log P) of the four dominant GXM motifs. We observed the following trend in the predicted lipophilicity of GXM carbohydrate motifs: M4 (dominant in serotype C, log P 2.12) > M3 (dominant in serotype B, log P 2.01) > M2 (dominant in serotype A, log P 1.9) > M1 (dominant in serotype D, log P 1.79) (Fig. 3C).

Based on the rationale that polysaccharides enriched in a greater number of hydroxyl groups would have higher hydrophilicity, we counted the number of hydroxyl groups of each dominant GXM motif (Fig. 3C). The M4 motif (dominant in serotype C) contained the highest number of hydroxyl groups, 21, followed by 19 hydroxyl groups in M3 (dominant in serotype B), 17 hydroxyl groups in M2 (dominant in serotype A), and 15 hydroxyl groups in M1 (dominant in serotype D).

Next, we wanted to investigate if the cell wall composition influences the CSH of C. neoformans. The enzymes chitin deacetylases, encoded by the cda gene family, deacetylate chitin, a hydrophobic polymer that is an important cell wall component, to chitosan, a hydrophilic polymer (29). We found no significant differences between wild type and strains knocked out for cda1 and for cda1, cda2, and cda3 (Fig. 3D).

CSH of unopsonized C. neoformans correlates with phagocytosis by A. castellanii.To test whether CSH influences phagocytosis by soil predators like the amoeba, we incubated fungal and protozoal cells and estimated the phagocytosis index. We found a positive and linear correlation between CSH of C. neoformans strains and phagocytosis index of C. neoformans strains by A. castellanii (Fig. 4). In this series of isolates, the phagocytosis index also correlated with strain serotype.

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

CSH of C. neoformans correlates with phagocytosis of C. neoformans by natural predator A. castellanii. Significant positive linear correlation (R2 = 0.5722) between CSH of C. neoformans strains and phagocytosis index by A. castellanii. Phagocytosis index is estimated by fluorescence microscopy as the number of C. neoformans cells labeled by Uvitex internalized per 100 A. castellanii cells. Error bars represent the standard deviation of the mean.

Effect of antibody binding on CSH.Previous studies have demonstrated that capsule antibody binding alters capsule structure and changes the surface charge of C. neoformans (16, 17). This led us to investigate the effect of binding of capsular antibodies to C. neoformans on the CSH. We demonstrated that binding of capsular antibody 18B7 (30) increases CSH in a concentration-dependent manner, while binding of nonprotective antibody 13F1 has no significant effect on the CSH of C. neoformans cells grown in the capsule induction medium (Fig. 5).

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

Binding of protective capsule antibodies influences CSH. Incubation of C. neoformans strain H99 grown in the capsule induction medium (MM) with protective capsular antibody 18B7 significantly increased CSH in a concentration-dependent manner, while 12A1 decreased CSH and 13F1 had no significant effect on CSH. CSH was determined by MATH assay in 2 to 3 biological replicates, as indicated by data points. Error bars represent the standard deviation of the mean. Ordinary one-way analysis of variance was used to compare the CSH of untreated C. neoformans strain H99 with the CSH of H99 cells treated with different antibodies. The following symbols were used to annotate the statistical significance of the results: ns, P > 0.05; *, P ≤ 0.05; ***, P ≤ 0.001.

DISCUSSION

In this study, we measured the CSH of C. neoformans and found considerable interstrain variation. When CSH was estimated by hydrophobic microsphere assay, C. neoformans serotype D strains were likely to be more hydrophobic than C. neoformans serotype A strains, with the caveat that we analyzed a relatively small set of strains from each serotype. We also demonstrated that CSH is a biophysical parameter that may influence the interaction of yeast cells with the environmental predator Acanthamoeba castellanii. Finally, we demonstrated that the binding of a protective capsular antibody alters the CSH.

An earlier study suggested that capsule and protective antiserum binding influenced hydrophobicity of C. neoformans (31). They reported no correlation between CSH and phagocytosis of C. neoformans by mouse peritoneal macrophages (31). The difference between our observations and the prior report may be attributed to the differences in methodologies. In the prior study, hydrophobicity was estimated from the number of cells that bound to hydrophobic columns, and the cells were fixed with formalin, which may have altered surface properties of the yeast. In this study, we have used the MATH assay, which relies on the interaction of microbes with hydrophobic solvents to calculate CSH (Fig. 1A) (32). In addition, we have used a hydrophobic microsphere assay that quantitates the interaction between hydrophobic beads and the yeast, visualized under a bright-field microscope, to estimate the CSH (Fig. 1B) (20).

C. neoformans polysaccharides, like GXM, are essential components required in the formation of microbial communities called biofilms that are protective for the fungi (33). C. neoformans biofilms have been reported on medical devices (34, 35). Biofilm-associated cells have been associated with increased tolerance against antifungal drugs and phagocytic cells, as they upregulate proteins associated with host defense (36–38). In vivo, C. neoformans forms biofilm-like structures called cryptococcomas that could play a role in its neurotropism (39). The surface property of cells may affect the aggregation of microbial communities in biofilms. Interestingly, ATCC 24067 and B3501 strains, which are highly hydrophobic, also form biofilms more easily than the H99 strain, which is relatively less hydrophobic (Fig. 1) (36, 37). A similar correlation between the formation of biofilm and CSH was observed in Candida spp. (21, 40, 41) and in bacteria (42). Flocculation, another multicellular phenotype observed in yeasts, has been observed in C. neoformans cells during growth in certain media (43) and could be caused by changes in CSH, as reported for brewer’s yeast (44).

Amoebas are natural predators of Cryptococcus species (22, 45) and have emerged as a powerful tool for studying mechanisms of intracellular pathogenesis and evolution of virulence (46, 47). A growing body of evidence suggests that virulence traits have emerged in environmental fungi, including Cryptococcus species, because of the selection pressure that results from fungus-amoeba interaction (48). Our finding that the more hydrophobic Cryptococcus strains were more readily phagocytosed is congruent with the observation that amoebas can phagocytose hydrophobic particles (24), although these mechanisms are not well understood. There is a remarkable correspondence between C. neoformans virulence traits that influence phagocytosis and enable survival of the fungi in A. castellanii and in human macrophages (46). For instance, the capsule of C. neoformans masks cell wall components that are recognized by innate immune receptors (49), and the absence of capsule leads to poor survival of C. neoformans incubated with A. castellanii (46). In vitro studies of macrophage and C. neoformans interaction usually require opsonins such as capsular antibodies and complement (50, 51) for phagocytosis by innate immune cells. Since opsonins change the CSH of C. neoformans and without opsonins phagocytosis of cryptococcal cells by macrophages is essentially nil (52), comparable studies with mammalian phagocytic cells are difficult to do. Studying the effect of CSH on phagocytosis in amoebas may give insights into factors independent of opsonin-receptor interaction that may influence phagocytosis in macrophages.

Murine antibodies that recognize capsular epitopes of C. neoformans can confer passive protection on the host and enhance macrophage activity (53, 54). In addition to facilitating phagocytosis of the yeast, the murine IgG antibody 18B7 (30) alters capsule stiffness and impairs cellular replication of the yeast (17), significantly alters the cell surface charge (16), and has a catalytic activity that breaks down the capsule (55). In this study, we report that monoclonal antibody (MAb) 18B7 binding significantly increased the hydrophobicity of the cryptococcal cell surface in a concentration-dependent manner, while a nonprotective antibody, IgM 13F1, did not alter the CSH. We may attribute the differential effect of changes in CSH induced by MAbs 13F1 and 18B7 to the pattern of MAb binding, since MAb 18B7 binds near the surface in an annular pattern (17, 30, 56), while MAb 13F1 binds throughout the capsule in a punctate pattern (57, 58). There is precedence for our observation in the encapsulated bacterium Klebsiella aerogenes, where the pattern of diffusion of some MAbs through the polysaccharide capsule has been shown to influence the cell surface hydrophobicity (59, 60).

A surprising result in our study was that some C. neoformans strains manifest a considerably higher CSH than others, despite being surrounded by a hydrophilic capsule. The origin and mechanism for variability in CSH in these strains are not understood. Glycans are intrinsically hydrophilic molecules. Lipophilicity for glycans may be described by the partition coefficient (P), which is quantified as the distribution of a compound between two immiscible solvents, like water and octanol (61). While prior studies have compared the lipophilicities for monosaccharides, these efforts are not standardized in the field (14). For small molecules, log P can be accurately predicted by an equation proposed by Mannhold et al., although the accuracy of the prediction decreases with an increase in nonhydrogen atoms (28). In this study, we used this calculation to predict and compare the lipophilicities of capsular carbohydrate motifs (28), with the caveat that the suitability of these equations for molecules larger than monosaccharides is uncertain. The predicted calculated lipophilicity of GXM oligosaccharide motifs was positive, incorrectly suggesting that the polymers would preferentially partition into an organic solvent. The M1 motif, which is dominant on the C. neoformans serotype D strains, was found to be less lipophilic than M3 and M4 motifs that are dominant in C. gattii serotype B and C. neoformans serotype A strains, respectively (Fig. 3D). This goes against our experimental observation that some C. neoformans serotype D strains were more hydrophobic than serotype B and A strains (Fig. 2) and implies that simple calculations of lipophilicity do not explain our findings. Instead, we suspect that the measured hydrophobicity stems from higher-order polysaccharide structures that could present different molecular surfaces in their interaction with the solvent.

The dynamic and noncrystalline nature of polysaccharides makes it challenging to obtain defined structures and to relate the structure of glycans to their activity and biological roles. Yet, we know that the flexibility of the oligosaccharide polymer is influenced by intra- and intermolecular hydrogen bonds. Theoretical predictions suggest that α-(1→3)-mannan forms weak intermolecular hydrogen bonds, resulting in a polymer with a flexible structure that allows for many hydroxyl groups to interact with water (12). The primary component in the capsule of C. neoformans is built upon repeating α-(1→3)-mannose triads, which would contribute to the observation that 95% of capsule’s weight comes from water (11). We also found that the number of hydroxyl groups in each motif (Fig. 3C) was inversely related to the observed CSH. The dominant motif M1 in the capsule of C. neoformans serotype D had fewer hydroxyl groups and the strains of serotype D tend to have higher CSH, compared to the number of hydroxyl groups in dominant motifs M2 and M3 of serotype A and B, whose strains had comparatively lower CSH. Fewer hydroxyl groups result in fewer opportunities for hydrogen bonding between the polysaccharide and water, which could translate into fewer hydrophilic structures with higher CSH.

It is also important to note that the motifs that enrich the capsule may differ between strains of the same serotype (10). For example, in C. neoformans serotype D strain 24067, capsular polysaccharide chemotyping suggests that the M1 motif dominates 100% of the strain, while C. neoformans serotype D strain B3502 is composed of the dominant M1 (52%) motif and the M6 (48%) motif (10). This may contribute to the variation of CSH within strains grouped in serotype D (Fig. 2).

In addition, we sought to explore whether the composition of the cell wall, in particular the chitin-chitosan content in the cell wall, which is regulated by cda genes encoding chitin deacetylases (62), may influence the adhesion of C. neoformans to various surfaces (63). The role of these enzymes in adhesion has also been described for the plant-pathogenic fungus Magnaporthe oryzae (64). In C. neoformans, chitosan is reported to be important for cell wall integrity, such that mutants that lack the cda genes display attenuated virulence (29, 62, 65). In addition, while chitin is hydrophobic, the deacetylated form chitosan is relatively hydrophilic because it is enriched in amines, a hydrophilic functional group (66, 67). When we compared the hydrophobicity of mutants that are deficient in chitosan with that of the wild type, we found no significant differences. We also sought to alter the cell wall composition by inducing the formation of the hydrophobic pigment melanin in C. neoformans strain H99 by growing the cells with and without the catecholamine precursor l-3,4-dihydroxyphenylalanine (l-DOPA). We did not observe any notable difference between binding levels of hydrophobic beads to melanized and nonmelanized cells (experiment performed once; data not shown). Therefore, our data indicate that the capsular polysaccharide that surrounds the cell, and not the cell wall composition, influences the hydrophobicity of the C. neoformans cell surface. Lipophilic structures have been reported in the capsule, which might extend to the surface and influence the hydrophobicity of the cell surface (12, 68).

In summary, we report that CSH of Cryptococcus species can differ significantly depending on the strain. We have also demonstrated the correlation of the biophysical parameter CSH with the phagocytosis by A. castellanii and shown that protective antibodies that bind to the capsule of C. neoformans can influence the hydrophobicity of C. neoformans. The findings that C. neoformans strains differ in CSH and that changes to this cell surface property correlates with biological properties suggest that the investigation of how this parameter is established and maintained could provide new insights into capsular structure.

MATERIALS AND METHODS

Strains and culture of C. neoformans and C. gattii.Cryptococcus neoformans and C. gattii strains (Table 1) stored as frozen stocks at −80°C were streaked onto Sabouraud agar plates and incubated at 30°C for 48 h. The plates were stored at 4°C for use up to 1 week. Multiple colonies were selected and inoculated into 5 ml of liquid medium and Sabouraud broth and incubated at 30°C with shaking for 2 days. For capsule induction, 106 cells/ml were washed twice in phosphate-buffered saline (PBS) and inoculated into MM (10 mM MgSO4, 29.3 mM KH2PO4, 13 mM glycine, 3 μM thiamine-HCl, and 15 mM dextrose, with pH adjusted to 5.5).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

Strains of C. neoformans and C. gattii used in the present study

Antibody incubation.C. neoformans (H99) grown in MM was washed twice in PBS. Protective and nonprotective capsular antibodies, 18B7, 12A1, and 13F1 (69), respectively, were incubated for 1 h at 30°C with shaking. The CSH percentage (CSH%) was determined by MATH and microsphere assays as detailed below.

Estimation of CSH by MATH.CSH was estimated by the MATH assay as described in reference 32. Yeast cultures were washed twice in PBS and resuspended in 3 ml of PBS at an estimated initial optical density (OD) of 0.2 to 0.4 recorded as A0. An 0.4-ml amount of n-hexadecane was added, and the mixture was vortexed for 30 s and incubated at 30°C for 2 min to allow the layers to separate. Final OD (A1) of the aqueous layer was recorded and estimated as an average from 3 technical replicates in a 96-well plate read by an Emax Plus microplate reader (Molecular Devices). CSH% was estimated as [1 − (A0/A1)] × 100.

Estimation of CSH by hydrophobic microsphere assay.CSHs of C. neoformans and C. gattii were estimated by the method detailed in reference 20 by adding 9.02 × 108 0.8-μm green hydrophobic beads (Bang Laboratories) to 2 ml of 2 × 106 cells/ml in sodium phosphate buffer (0.05 M, pH 7.2) in clean glass tubes. After equilibration at room temperature (RT) for 2 min, the mixture was vortexed vigorously for 30 s. Cells were imaged at 40×, 100 cells were counted, and the percentage of cells having >3 attached microspheres was considered the CSH% value.

Acanthamoeba castellanii culture.Acanthamoeba castellanii strain 30234 was obtained from the American Type Culture Collection (ATCC). Cultures were maintained in PYG broth (ATCC medium 712) at 25°C according to instructions from ATCC.

Acanthamoeba castellanii phagocytosis index.The phagocytosis index was estimated as detailed in reference 70 with minor modifications. Briefly, 5 × 105 cells/ml of A. castellanii were incubated in 35-mm no. 1.5 coverslip MatTek dishes with Dulbecco’s PBS (DPBS) (Ca2+ and Mg2+) for 3 to 4 h. C. neoformans or C. gattii strains were incubated with 10 μg/ml Uvitex (fungal cell wall dye), inoculated at a multiplicity of infection (MOI) of 1 and incubated for 2 h at 25°C. The cells were imaged using a Zeiss Axiovert 200M inverted microscope with a 20× phase objective. Phagocytosis index was estimated by counting the number of C. neoformans or C. gattii cells engulfed per 100 amoeboid cells.

Estimation of lipophilicity and number of hydroxyl groups in carbohydrate motifs.The lipophilicity of the carbohydrate motif dominant in the capsule of an C. neoformans serotype was estimated by the method described by Mannhold et al. (28), as the log of the partition coefficient (P): log P = 1.46 (±0.02) + 0.11 (±0.001)NC − 0.11 (±0.001)NHET, where NC is the number of carbon atoms in a molecule and NHET is the number of hetero atoms.

The number of hydroxyl groups in each motif of C. neoformans capsule was counted manually, as proxy for the number of hydrogen bond donor and acceptor atoms.

ACKNOWLEDGMENTS

A.C. is supported by grants HL059842, AI052733, and AI152078. C.C. was funded by an Irish Research Council postgraduate award (GOIPG/2016/998).

Special thanks to Jennifer K. Lodge at Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, for generously gifting us with the cda knockout strains. Special thanks to Radames J. B. Cordero for valuable discussions of experimental design and edits to the manuscript and to Daniel F. Q. Smith for the valuable contribution of editing the figures.

R.V. designed and conducted the experiments, analyzed the data, and wrote the manuscript. C.C. performed computation and theoretical analysis and wrote the manuscript. C.D. and Q.D. conducted experiments and analyzed data. A.C. contributed to the experimental design, supervised the experiments, and edited and wrote parts of the manuscript.

FOOTNOTES

    • Received April 6, 2020.
    • Accepted April 14, 2020.
  • Copyright © 2020 Vij et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Walsh NM,
    2. Botts MR,
    3. McDermott AJ,
    4. Ortiz SC,
    5. Wüthrich M,
    6. Klein B,
    7. Hull CM
    . 2019. Infectious particle identity determines dissemination and disease outcome for the inhaled human fungal pathogen Cryptococcus. PLoS Pathog 15:e1007777. doi:10.1371/journal.ppat.1007777.
    OpenUrlCrossRef
  2. 2.↵
    1. Kwon-Chung KJ,
    2. Bennett JE,
    3. Wickes BL,
    4. Meyer W,
    5. Cuomo CA,
    6. Wollenburg KR,
    7. Bicanic TA,
    8. Castañeda E,
    9. Chang YC,
    10. Chen J,
    11. Cogliati M,
    12. Dromer F,
    13. Ellis D,
    14. Filler SG,
    15. Fisher MC,
    16. Harrison TS,
    17. Holland SM,
    18. Kohno S,
    19. Kronstad JW,
    20. Lazera M,
    21. Levitz SM,
    22. Lionakis MS,
    23. May RC,
    24. Ngamskulrongroj P,
    25. Pappas PG,
    26. Perfect JR,
    27. Rickerts V,
    28. Sorrell TC,
    29. Walsh TJ,
    30. Williamson PR,
    31. Xu J,
    32. Zelazny AM,
    33. Casadevall A
    . 2017. The case for adopting the “species complex” nomenclature for the etiologic agents of cryptococcosis. mSphere 2:e00357-16. doi:10.1128/mSphere.00357-16.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Kwon-Chung KJ,
    2. Fraser JA,
    3. Doering TL,
    4. Wang Z,
    5. Janbon G,
    6. Idnurm A,
    7. Bahn Y-S
    . 2014. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med 4:a019760. doi:10.1101/cshperspect.a019760.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Meyer W,
    2. Gilgado F,
    3. Ngamskulrungroj P,
    4. Trilles L,
    5. Hagen F,
    6. Castañeda E,
    7. Boekhout T
    . 2011. Molecular typing of the Cryptococcus neoformans/Cryptococcus gattii species complex, p 327–357. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
  5. 5.↵
    1. Charlier C,
    2. Chrétien F,
    3. Baudrimont M,
    4. Mordelet E,
    5. Lortholary O,
    6. Dromer F
    . 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166:421–432. doi:10.1016/S0002-9440(10)62265-1.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Cordero RJB,
    2. Frases S,
    3. Guimaräes AJ,
    4. Rivera J,
    5. Casadevall A
    . 2011. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol 79:1101–1117. doi:10.1111/j.1365-2958.2010.07511.x.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Gates MA,
    2. Thorkildson P,
    3. Kozel TR
    . 2004. Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol 52:13–24. doi:10.1111/j.1365-2958.2003.03957.x.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Crawford CJ,
    2. Cordero RJB,
    3. Guazzelli L,
    4. Wear MP,
    5. Bowen A,
    6. Oscarson S,
    7. Casadevall A
    . 2020. Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe. J Biol Chem 295:4327–4340. doi:10.1074/jbc.RA119.012251.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Cherniak R,
    2. Morris LC,
    3. Belay T,
    4. Spitzer ED,
    5. Casadevall A
    . 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun 63:1899–1905. doi:10.1128/IAI.63.5.1899-1905.1995.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Cherniak R,
    2. Valafar H,
    3. Morris LC,
    4. Valafar F
    . 1998. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5:146–159. doi:10.1128/CDLI.5.2.146-159.1998.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Maxson ME,
    2. Cook E,
    3. Casadevall A,
    4. Zaragoza O
    . 2007. The volume and hydration of the Cryptococcus neoformans polysaccharide capsule. Fungal Genet Biol 44:180–186. doi:10.1016/j.fgb.2006.07.010.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Almond A
    . 2005. Towards understanding the interaction between oligosaccharides and water molecules. Carbohydr Res 340:907–920. doi:10.1016/j.carres.2005.01.014.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Yu Y,
    2. Tyrikos‐Ergas T,
    3. Zhu Y,
    4. Fittolani G,
    5. Bordoni V,
    6. Singhal A,
    7. Fair RJ,
    8. Grafmüller A,
    9. Seeberger PH,
    10. Delbianco M
    . 2019. Systematic hydrogen-bond manipulations to establish polysaccharide structure–property correlations. Angew Chem 131:13261–13266. doi:10.1002/ange.201906577.
    OpenUrlCrossRef
  14. 14.↵
    1. Fu D,
    2. O’Neill RA
    . 1995. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography. Anal Biochem 227:377–384. doi:10.1006/abio.1995.1294.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Delbianco M,
    2. Kononov A,
    3. Poveda A,
    4. Yu Y,
    5. Diercks T,
    6. Jiménez-Barbero J,
    7. Seeberger PH
    . 2018. Well-defined oligo- and polysaccharides as ideal probes for structural studies. J Am Chem Soc 140:5421–5426. doi:10.1021/jacs.8b00254.
    OpenUrlCrossRef
  16. 16.↵
    1. Nosanchuk JD,
    2. Casadevall A
    . 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 65:1836–1841. doi:10.1128/IAI.65.5.1836-1841.1997.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Cordero RJB,
    2. Pontes B,
    3. Frases S,
    4. Nakouzi AS,
    5. Nimrichter L,
    6. Rodrigues ML,
    7. Viana NB,
    8. Casadevall A
    . 2013. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. J Immunol 190:317–323. doi:10.4049/jimmunol.1202324.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Cordero RJB,
    2. Pontes B,
    3. Guimarães AJ,
    4. Martinez LR,
    5. Rivera J,
    6. Fries BC,
    7. Nimrichter L,
    8. Rodrigues ML,
    9. Viana NB,
    10. Casadevall A
    . 2011. Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect Immun 79:4990–5000. doi:10.1128/IAI.05789-11.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Krasowska A,
    2. Sigler K
    . 2014. How microorganisms use hydrophobicity and what does this mean for human needs? Front Cell Infect Microbiol 4:112. doi:10.3389/fcimb.2014.00112.
    OpenUrlCrossRef
  20. 20.↵
    1. Hazen KC,
    2. Brawner DL,
    3. Riesselman MH,
    4. Jutila MA,
    5. Cutler JE
    . 1991. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect Immun 59:907–912. doi:10.1128/IAI.59.3.907-912.1991.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Borecká-Melkusová S,
    2. Bujdáková H
    . 2008. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment. Can J Microbiol 54:718–724. doi:10.1139/W08-060.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Castellani A
    . 1930. An amoeba growing in cultures of a yeast. J Trop Med Hyg 33:188–191.
    OpenUrl
  23. 23.↵
    1. Mylonakis E,
    2. Ausubel FM,
    3. Perfect JR,
    4. Heitman J,
    5. Calderwood SB
    . 2002. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A 99:15675–15680. doi:10.1073/pnas.232568599.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Vogel G,
    2. Thilo L,
    3. Schwarz H,
    4. Steinhart R
    . 1980. Mechanism of phagocytosis in Dictyostelium discoideum: phagocytosis is mediated by different recognition sites as disclosed by mutants with altered phagocytotic properties. J Cell Biol 86:456–465. doi:10.1083/jcb.86.2.456.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Zaragoza O,
    2. Casadevall A
    . 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6:10–15. doi:10.1251/bpo68.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Vaishnav VV,
    2. Bacon BE,
    3. O’Neill M,
    4. Cherniak R
    . 1998. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306:315–330. doi:10.1016/S0008-6215(97)10058-1.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Jacobson ES,
    2. Ayers DJ,
    3. Harrell AC,
    4. Nicholas CC
    . 1982. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol 150:1292–1296. doi:10.1128/JB.150.3.1292-1296.1982.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Mannhold R,
    2. Poda GI,
    3. Ostermann C,
    4. Tetko IV
    . 2009. Calculation of molecular lipophilicity: state-of-the-art and comparison of logP methods on more than 96,000 compounds. J Pharm Sci 98:861–893. doi:10.1002/jps.21494.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Baker LG,
    2. Specht CA,
    3. Donlin MJ,
    4. Lodge JK
    . 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 6:855–867. doi:10.1128/EC.00399-06.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Casadevall A,
    2. Cleare W,
    3. Feldmesser M,
    4. Glatman-Freedman A,
    5. Goldman DL,
    6. Kozel TR,
    7. Lendvai N,
    8. Mukherjee J,
    9. Pirofski LA,
    10. Rivera J,
    11. Rosas AL,
    12. Scharff MD,
    13. Valadon P,
    14. Westin K,
    15. Zhong Z
    . 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42:1437–1446. doi:10.1128/AAC.42.6.1437.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Kozel TR
    . 1983. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans. Infect Immun 39:1214–1219. doi:10.1128/IAI.39.3.1214-1219.1983.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Rosenberg M
    . 1984. Bacterial adherence to hydrocarbons: a useful technique for studying cell surface hydrophobicity. FEMS Microbiol Lett 22:289–295. doi:10.1111/j.1574-6968.1984.tb00743.x.
    OpenUrlCrossRefWeb of Science
  33. 33.↵
    1. Martinez LR,
    2. Casadevall A
    . 2007. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol 73:4592–4601. doi:10.1128/AEM.02506-06.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Banerjee U,
    2. Gupta K,
    3. Venugopal P
    . 1997. A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans. J Med Vet Mycol 35:139–141. doi:10.1080/02681219780001031.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Walsh TJ,
    2. Schlegel R,
    3. Moody MM,
    4. Costerton JW,
    5. Salcman M
    . 1986. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18:373–375. doi:10.1227/00006123-198603000-00025.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Martinez LR,
    2. Casadevall A
    . 2005. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73:6350–6362. doi:10.1128/IAI.73.10.6350-6362.2005.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Martinez LR,
    2. Casadevall A
    . 2006. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 50:1021–1033. doi:10.1128/AAC.50.3.1021-1033.2006.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Santi L,
    2. Beys-da-Silva WO,
    3. Berger M,
    4. Calzolari D,
    5. Guimarães JA,
    6. Moresco JJ,
    7. Yates JR
    . 2014. Proteomic profile of Cryptococcus neoformans biofilm reveals changes in metabolic processes. J Proteome Res 13:1545–1559. doi:10.1021/pr401075f.
    OpenUrlCrossRef
  39. 39.↵
    1. Aslanyan L,
    2. Sanchez DA,
    3. Valdebenito S,
    4. Eugenin EA,
    5. Ramos RL,
    6. Martinez LR
    . 2017. The crucial role of biofilms in Cryptococcus neoformans survival within macrophages and colonization of the central nervous system. J Fungi 3:10. doi:10.3390/jof3010010.
    OpenUrlCrossRef
  40. 40.↵
    1. Bujdáková H,
    2. Didiášová M,
    3. Drahovská H,
    4. Černáková L
    . 2013. Role of cell surface hydrophobicity in Candida albicans biofilm. Cent Eur J Biol 8:259–262.
    OpenUrl
  41. 41.↵
    1. Silva-Dias A,
    2. Miranda IM,
    3. Branco J,
    4. Monteiro-Soares M,
    5. Pina-Vaz C,
    6. Rodrigues AG
    . 2015. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front Microbiol 6:205. doi:10.3389/fmicb.2015.00205.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Mirani ZA,
    2. Fatima A,
    3. Urooj S,
    4. Aziz M,
    5. Khan MN,
    6. Abbas T
    . 2018. Relationship of cell surface hydrophobicity with biofilm formation and growth rate: a study on Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. Iran J Basic Med Sci 21:760–769. doi:10.22038/IJBMS.2018.28525.6917.
    OpenUrlCrossRef
  43. 43.↵
    1. Li L,
    2. Zaragoza O,
    3. Casadevall A,
    4. Fries BC
    . 2006. Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cell Microbiol 8:1730–1739. doi:10.1111/j.1462-5822.2006.00742.x.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Smit G,
    2. Straver MH,
    3. Lugtenberg BJ,
    4. Kijne JW
    . 1992. Flocculence of Saccharomyces cerevisiae cells is induced by nutrient limitation, with cell surface hydrophobicity as a major determinant. Appl Environ Microbiol 58:3709–3714. doi:10.1128/AEM.58.11.3709-3714.1992.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Castellani A
    . 1955. Phagocytic and destructive action of Hartmanella castellanii (Amoeba castellanii) on pathogenic encapsulated yeast-like fungi Torulopsis neoformans (Cryptococcus neoformans)]. Ann Inst Pasteur (Paris) 89:1–7.
    OpenUrlPubMed
  46. 46.↵
    1. Steenbergen JN,
    2. Shuman HA,
    3. Casadevall A
    . 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98:15245–15250. doi:10.1073/pnas.261418798.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Rizzo J,
    2. Albuquerque PC,
    3. Wolf JM,
    4. Nascimento R,
    5. Pereira MD,
    6. Nosanchuk JD,
    7. Rodrigues ML
    . 2017. Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii. Fungal Biol 121:602–614. doi:10.1016/j.funbio.2017.04.002.
    OpenUrlCrossRef
  48. 48.↵
    1. Casadevall A,
    2. Fu MS,
    3. Guimaraes AJ,
    4. Albuquerque P
    . 2019. The ‘amoeboid predator-fungal animal virulence’ hypothesis. J Fungi 5:10. doi:10.3390/jof5010010.
    OpenUrlCrossRef
  49. 49.↵
    1. O’Meara TR,
    2. Alspaugh JA
    . 2012. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev 25:387–408. doi:10.1128/CMR.00001-12.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Kelly RM,
    2. Chen J,
    3. Yauch LE,
    4. Levitz SM
    . 2005. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun 73:592–598. doi:10.1128/IAI.73.1.592-598.2005.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Zhong Z,
    2. Pirofski LA
    . 1996. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies. Infect Immun 64:3446–3450. doi:10.1128/IAI.64.9.3446-3450.1996.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Macura N,
    2. Zhang T,
    3. Casadevall A
    . 2007. Dependence of macrophage phagocytic efficacy on antibody concentration. Infect Immun 75:1904–1915. doi:10.1128/IAI.01258-06.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    1. Mukherjee J,
    2. Scharff MD,
    3. Casadevall A
    . 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 60:4534–4541. doi:10.1128/IAI.60.11.4534-4541.1992.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. Mukherjee S,
    2. Lee SC,
    3. Casadevall A
    . 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 63:573–579. doi:10.1128/IAI.63.2.573-579.1995.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Bowen A,
    2. Wear MP,
    3. Cordero RJB,
    4. Oscarson S,
    5. Casadevall A
    . 2017. A monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan manifests hydrolytic activity for both peptides and polysaccharides. J Biol Chem 292:417–434. doi:10.1074/jbc.M116.767582.
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Larsen RA,
    2. Pappas PG,
    3. Perfect J,
    4. Aberg JA,
    5. Casadevall A,
    6. Cloud GA,
    7. James R,
    8. Filler S,
    9. Dismukes WE
    . 2005. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49:952–958. doi:10.1128/AAC.49.3.952-958.2005.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Feldmesser M,
    2. Rivera J,
    3. Kress Y,
    4. Kozel TR,
    5. Casadevall A
    . 2000. Antibody interactions with the capsule of Cryptococcus neoformans. Infect Immun 68:3642–3650. doi:10.1128/iai.68.6.3642-3650.2000.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. MacGill TC,
    2. MacGill RS,
    3. Casadevall A,
    4. Kozel TR
    . 2000. Biological correlates of capsular (quellung) reactions of cryptococcus neoformans. J Immunol 164:4835–4842. doi:10.4049/jimmunol.164.9.4835.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Held TK,
    2. Jendrike NRM,
    3. Rukavina T,
    4. Podschun R,
    5. Trautmann M
    . 2000. Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains. Infect Immun 68:2402–2409. doi:10.1128/iai.68.5.2402-2409.2000.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Williams P,
    2. Lambert PA,
    3. Brown M
    . 1988. Penetration of immunoglobulins through the Klebsiella capsule and their effect on cell-surface hydrophobicity. J Med Microbiol 26:29–35. doi:10.1099/00222615-26-1-29.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Chiou CT,
    2. Freed VH,
    3. Schmedding DW,
    4. Kohnert RL
    . 1977. Partition coefficient and bioaccumulation of selected organic chemicals. Environ Sci Technol 11:475–478. doi:10.1021/es60128a001.
    OpenUrlCrossRef
  62. 62.↵
    1. Upadhya R,
    2. Baker LG,
    3. Lam WC,
    4. Specht CA,
    5. Donlin MJ,
    6. Lodge JK
    . 2018. Cryptococcus neoformans Cda1 and its chitin deacetylase activity are required for fungal pathogenesis. mBio 9:e02087-18. doi:10.1128/mBio.02087-18.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Teixeira PAC,
    2. Penha LL,
    3. Mendonça-Previato L,
    4. Previato JO
    . 2014. Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells. Front Cell Infect Microbiol 4:106. doi:10.3389/fcimb.2014.00106.
    OpenUrlCrossRef
  64. 64.↵
    1. Geoghegan IA,
    2. Gurr SJ
    . 2016. Chitosan mediates germling adhesion in Magnaporthe oryzae and is required for surface sensing and germling morphogenesis. PLoS Pathog 12:e1005703. doi:10.1371/journal.ppat.1005703.
    OpenUrlCrossRef
  65. 65.↵
    1. Baker LG,
    2. Specht CA,
    3. Lodge JK
    . 2011. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot Cell 10:1264–1268. doi:10.1128/EC.05138-11.
    OpenUrlAbstract/FREE Full Text
  66. 66.↵
    1. Jollès P,
    2. Muzzarelli R
    . 1999. Chitin and chitinases. Birkhäuser Verlag, Basel, Switzerland.
  67. 67.↵
    1. Ye J-R,
    2. Chen L,
    3. Zhang Y,
    4. Zhang Q-C,
    5. Shen Q
    . 2014. Turning the chitosan surface from hydrophilic to hydrophobic by layer-by-layer electro-assembly. RSC Adv 4:58200–58203. doi:10.1039/C4RA10327K.
    OpenUrlCrossRef
  68. 68.↵
    1. Nicola AM,
    2. Frases S,
    3. Casadevall A
    . 2009. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryot Cell 8:1373–1380. doi:10.1128/EC.00044-09.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Mukherjee J,
    2. Casadevall A,
    3. Scharff MD
    . 1993. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 177:1105–1116. doi:10.1084/jem.177.4.1105.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    1. Fu MS,
    2. Casadevall A
    . 2018. Divalent metal cations potentiate the predatory capacity of amoeba for Cryptococcus neoformans. Appl Environ Microbiol 84:e01717-17. doi:10.1128/AEM.01717-17.
    OpenUrlAbstract/FREE Full Text
  71. 71.↵
    1. Varki A,
    2. Cummings RD,
    3. Aebi M,
    4. Packer NH,
    5. Seeberger PH,
    6. Esko JD,
    7. Stanley P,
    8. Hart G,
    9. Darvill A,
    10. Kinoshita T,
    11. Prestegard JJ,
    12. Schnaar RL,
    13. Freeze HH,
    14. Marth JD,
    15. Bertozzi CR,
    16. Etzler ME,
    17. Frank M,
    18. Vliegenthart JF,
    19. Lütteke T,
    20. Perez S,
    21. Bolton E,
    22. Rudd P,
    23. Paulson J,
    24. Kanehisa M,
    25. Toukach P,
    26. Aoki-Kinoshita KF,
    27. Dell A,
    28. Narimatsu H,
    29. York W,
    30. Taniguchi N,
    31. Kornfeld S
    . 2015. Symbol nomenclature for graphical representations of glycans. Glycobiology 25:1323–1324. doi:10.1093/glycob/cwv091.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. Steenbergen JN,
    2. Casadevall A
    . 2000. Prevalence of Cryptococcus neoformans var. neoformans (serotype D) and Cryptococcus neoformans var. grubii (serotype A) isolates in New York City. J Clin Microbiol 38:1974–1976. doi:10.1128/JCM.38.5.1974-1976.2000.
    OpenUrlAbstract/FREE Full Text
  73. 73.↵
    1. Cleare W,
    2. Casadevall A
    . 1998. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays. Clin Diagn Lab Immunol 5:125–129. doi:10.1128/CDLI.5.2.125-129.1998.
    OpenUrlAbstract/FREE Full Text
  74. 74.↵
    1. Heitman J,
    2. Allen B,
    3. Alspaugh JA,
    4. Kwon-Chung KJ
    . 1999. On the origins of congenic MATα and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol 28:1–5. doi:10.1006/fgbi.1999.1155.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    1. Freij JB,
    2. Fu MS,
    3. De Leon Rodriguez CM,
    4. Dziedzic A,
    5. Jedlicka AE,
    6. Dragotakes Q,
    7. Rossi DCP,
    8. Jung EH,
    9. Coelho C,
    10. Casadevall A
    . 2018. Conservation of intracellular pathogenic strategy among distantly related cryptococcal species. Infect Immun 86:e00946-17. doi:10.1128/IAI.00946-17.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas
Raghav Vij, Carina Danchik, Conor Crawford, Quigly Dragotakes, Arturo Casadevall
mSphere Apr 2020, 5 (2) e00310-20; DOI: 10.1128/mSphere.00310-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas
Raghav Vij, Carina Danchik, Conor Crawford, Quigly Dragotakes, Arturo Casadevall
mSphere Apr 2020, 5 (2) e00310-20; DOI: 10.1128/mSphere.00310-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cell surface hydrophobicity (CSH)
Cryptococcus neoformans
Cryptococcus gattii
Acanthamoeba castellanii
capsular antibody
polysaccharide capsule

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042